Thalidomide Down-Regulates Transcript Levels of GC-Rich Promoter Genes in Multiple Myeloma
Liat Drucker(Meir Medical Center), Michael Lishner(Tel Aviv University), Tali Tohami(Tel Aviv University), Orit Uziel, Meir Lahav, Judith Radnay(Tel Aviv University), Shai Yarkoni, Hava Shapiro(Tel Aviv University)
Cited by 30
Related Papers
High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
|European Journal of Surgical Oncology|2006|63
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
|The FASEB Journal|2007|56
Simvastatin has deleterious effects on human first trimester placental explants
|Human Reproduction|2005|51
Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation
|Tumor Biology|2015|48
BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
|International Journal of Gynecological Cancer|2010|47